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Abstract  Hepatic  steatosis  is  a  common  condition,  the  prevalence  of  which  is  increasing  along
with non-alcoholic  hepatic  steatosis.  In  imaging,  it  can  present  in  a  typical  homogeneous  or  het-
erogeneous  way.  Some  forms  create  traps  in  imaging,  whether  localised  steatosis  is  concerned
or areas  which  have  been  spared  by  steatosis,  and  the  purpose  of  this  paper  is  to  explainsteatosis;
MRI
and illustrate  them.  The  role  of  different  imaging  methods  is  described  while  emphasizing  the
importance  of  MRI.
©  2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Deﬁnition
Steatosis  is  deﬁned  as  the  accumulation  of  fatty  acids  in  the  form  of  triglycerides  in  the
cytoplasm  of  hepatocytes.  In  histological  terms,  this  usually  appears  as  macrovacuolar
steatosis,  with  large  intracytoplasmic  vacuoles  displacing  the  nucleus  to  the  periphery
of  the  cells.  More  rarely,  microvacuolar  steatosis  is  seen,  which  consists  of  smaller  vac-
uoles  leaving  the  nucleus  in  a  central  position.  Microvacuolar  steatosis  can  occur  with  the
macrovacuolar  form.  When  it  is  present  alone,  particular  causes  should  be  sought:  steatosis
in  pregnancy,  Reye’s  syndrome,  and  certain  drug-induced  steatoses.
Table  1  summarises  the  most  commonly  observed  causes  of  classic  macrovacuolar
steatosis.  Alcohol  is  one  of  the  main  causes  of  hepatic  steatosis.  Non-alcoholic  steatosis
(non-alcoholic  fatty  liver  disease  [NAFLD])  is  mainly  observed  in  patients  with  metabolic
syndrome;  what  is  more,  it  is  considered  as  the  hepatic  manifestation  of  this  syndrome.
Unlike  steatosis  of  alcoholic  origin,  different  types  of  steatosis  and  evolutionary  proﬁles
are  seen  in  non-alcoholic  steatosis:  pure  steatosis,  steatohepatitis  or  even  cirrhosis.
∗ Corresponding author. Radiology Department, Assistance publique des Hôpitaux de Paris, AP—HP, hôpital Beaujon, 100, boulevard du
Général-Leclerc, 92110 Clichy, France.
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Table  1  Principal  causes  of  macrovacuolar  steatosis.
Very  common  Common  Uncommon  Congenital
Alcohol  Hepatitis  C  Nutrition  Genetic
Insulin  resistance  Medicinal  products  Parenteral  nutrition  Metabolic  overload
Obesity  Corticosteroids  Under-nutrition
Hypertriglyceridaemia  Chemotherapy  Weight  loss  Cystic  ﬁbrosis
Amiodarone  Bypass
Tamoxifen Extensive  resection  of  the  small  intestine
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them  were  instances  of  hypointensity  appearing  in  the  portalMethotrexate  Radi
In  steatohepatitis  (non-alcoholic  steatohepatitis  [NASH]),
teatosis  is  associated  with  necrotic-inﬂammatory  lesions
ith  hepatocyte  ballooning.  Mallory  bodies  may  be  seen.
ASH  can  present  various  degrees  of  ﬁbrosis  and  evolve
owards  cirrhosis.  Hepatocellular  carcinoma  complicates
his  condition  and  can  occur  during  cirrhosis  or  even  in  the
tages  prior  to  this  [1].
pidemiology
epatic  steatosis  has  become  a  very  common  cause  of  liver
isease  due  to  the  increased  prevalence  of  overweight  and
bese  individuals  in  the  world.  In  France,  more  than  46%
f  the  general  population  are  overweight  [2].  The  preva-
ence  of  metabolic  steatosis  varies  worldwide  between  43
nd  45%  [1],  and  is  lower  in  Asian  countries  than  in  West-
rn  countries.  It  is  much  higher  in  at-risk  populations,  such
s  patients  with  type  II  diabetes  or  obese  patients,  where
t  varies  between  50  and  90%  [1].  A  recent  French  survey
as  underlined  the  high  frequency  of  failure  to  recognise
teatohepatitis.  A  large  number  of  patients  being  monitored
y  endocrinologists  for  a  suspected  metabolic  syndrome  are
ot  referred  to  hepatologists.  In  addition,  the  diagnosis  of
teatohepatitis  is  difﬁcult  in  patients  with  normal  transam-
nases  [3].
hat is the role of radiologists in hepatic
teatosis?
hey  need  to  know:
how  to  recognise  hepatic  steatosis;
how  to  quantify  it;
how  to  attempt  to  differentiate  pure  steatosis  from
steatohepatitis;
how  to  avoid  the  traps  presented  by  hepatic  steatosis  in
imaging  that  will  be  illustrated  below.
xcessive diagnosis of steatosis
he  ﬁrst  difﬁculty  is  to  avoid  false  positives  for  steatosis.
he  imaging  presentation  of  steatosis  is  not  entirely  spe-
iﬁc.  With  ultrasound,  steatosis  increases  liver  echogenicity
nd  thus  increases  the  liver/kidney  and  liver/vascular  gradi-
nt.  There  are  however  other  causes  of  hyperechogenicity,
specially  overload  diseases.
p
i
lrapy
While  hypoattenuation,  sparing  the  vessels,  suggest
teatosis  in  CT,  this  appearance  can  also  be  encountered
uring  inﬁltration,  particularly  by  a  tumour,  and  enhance-
ent  parallel  with  the  rest  of  the  liver  is  not  totally  speciﬁc
or  steatosis  (Fig.  1).
MRI  is  of  course  the  most  sensitive  and  most  speciﬁc  imag-
ng  method  for  diagnosing  steatosis.  In  addition,  it  provides
he  best  quantiﬁcation  of  the  percentage  of  fat  within  the
iver.  The  signal  drop  on  opposed-phase  images,  which  are
btained  by  putting  the  water  protons  and  fat  protons  at
80◦,  is  perfectly  characteristic.  Iron  overload  is  a  classic
rap.  In  this  case,  a  signal  drop  is  seen  on  in-phase  images
ut  not  on  opposed-phase  images  in  1.5  Tesla  MRI  where  the
rst  echo  time  is  the  one  that  is  opposed-phase,  the  second
eing  in-phase.  This  is  not  a  question  of  hepatic  steatosis,
ut  of  increased  dephasing  of  the  signal  becoming  greater
ith  increasing  TE  values  (Fig.  2).
eterogeneous steatosis
eterogeneous  steatosis  does  not  always  pose  a  difﬁcult
iagnostic  problem.  Diagnosis  is  easy  when  the  condi-
ion  presents  as  a  linear  ﬁeld,  with  no  mass  effect,  and
ith  vascular  integrity.  This  ﬁeld  appears  homogeneous
nd  hyperechoic  with  ultrasound,  hypoattenuating  with  CT
oth  before  and  after  injection,  with  a  signal  drop  on  MRI
pposed-phase  T1-weighted  images.  It  is  even  possible  to
ee  a  greater  fall  in  the  border  of  the  area  richer  in  fat
han  the  rest  of  the  liver  (Fig.  3).  In  other  circumstances,
teatosis  can  be  misleading  as  it  assumes  a  pseudotumoral
orm.
ocalised area of steatosis or localised areas
pared by steatosis
here  is  usually  topographic  predominance  in  the  hetero-
eneous  distribution  of  steatosis.  These  areas  are  situated
lose  to  the  hilum  plate:  the  posterior  surface  of  segment  IV,
nterior  surface  of  segment  I,  posterior  surface  of  the  left
obe  and  on  either  side  of  the  gallbladder  (Fig.  4).  There  is
lassically  also  higher  incidence  of  localised  steatosis  close
o  the  round  ligament.  Macari  et  al.  [4]  found  a  high  per-
entage  of  abnormalities  close  to  the  round  ligament  using
RI  (in  21  of  the  121  patients  investigated).  The  majority  ofhase  and  most  did  not  show  a  signal  drop  on  opposed-phase
mages,  which  suggests  a  perfusion  disorder  much  more  than
ocalised  steatosis.
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Figure 1. a—c: tumoral inﬁltration of the left liver mimicking localised steatosis. Contrast-enhanced CT in the arterial, portal and late
phases. Hypoattenuating inﬁltration of the left liver without vascular involvement or mass effect, corresponding to metastatic inﬁltration.
Presence of a layer of ascites. Note the absence of vascular invasion.
Figure 2. Hepatic iron overload. In-phase (a) and opposed-phase (b) T1-weighted sequences. Drop in hepatic signal on the in-phase
sequence, explained by dephasing of the protons due to disturbance of the magnetic ﬁeld (high iron concentration in the liver). This signal
drop should not be taken for hepatic steatosis. Note that it may be a confusing factor if hepatic steatosis and iron overload occur together.
716  V.  Vilgrain  et  al.
Figure 3. MRI of heterogeneous steatosis: a: presence of marked hypointensity of the right liver on the T2-weighted sequence with fat
suppression; b, c: the right liver is hyperintense with in-phase T1-weighted sequence (b) and there is signal drop on the opposed-phase
image (c). Note an even more fatty border zone between the steatotic a
Figure 4. Main locations encountered in heterogeneous steatosis:
localised steatosis or spared area. The main areas (in blue) are the
posterior surface of segment IV, the anterior surface of segment
I, the posterior surface of the left lobe and on either side of the
gallbladder (gallbladder in green).
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fnd less steatotic liver.
In  patients  with  a  steatotic  liver,  Aubin  et  al.  [5]  showed
atty  sparing  of  the  perivesicular  segments  IV  and  V,  which
as  much  greater  in  patients  who  still  had  their  gallblad-
er  (78%)  than  in  cholecystectomised  patients  (33%).  These
uthors  therefore  suggested  a  venous  explanation,  as  there
re  almost  always  small  cystic  veins  that  drain  directly
nto  the  liver  and  which  are  interrupted  by  cholecystec-
omy.
Similarly,  when  CT  arterial  portography  was  the  exami-
ation  customarily  performed  in  preoperative  evaluation  of
iver  metastases,  a  large  number  of  cases  of  lack  of  perihilar
r  pericholecystic  enhancement  were  observed  after  selec-
ive  injection  into  the  superior  mesenteric  artery,  leading  to
he  assumption  that  venous  supply  to  these  territories  did
ot  come  directly  from  the  portal  vein,  but  perhaps  from
ther  branches.  This  was  conﬁrmed  by  Asian  work  which
emonstrated  that  patients  with  lack  of  enhancement  in
TAP  had  aberrant  venous  return  from  the  gastric  vein  or
uodenopancreatic  venous  arcade  [6—8].
The  physiopathological  explanation  for  these  steatoses  or
atty  sparings  preferentially  localised  in  certain  territories
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Figure 5. Coronal reconstruction of an abdominal CT scan in the portal phase showing the drainage of the gastric and duodenopancreatic
veins: a: normal drainage of the gastric veins and the superior branch of the posterior duodenopancreatic arcade (blue). These veins drain into
the trunk of the portal vein; b: aberrant drainage of a gastric vein draining directly into the liver (violet). The hepatic territory low in insulin
explains an area spared by the fat in a steatotic patient; c: aberrant drainage of the superior branch of the posterior duodenopancreatic
arcade draining directly into the liver (green). The hepatic territory receiving this posterior portal branch has a higher insulin level which
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was  supported  by  a  theory  concerning  insulin,  which  sti-
mulates  the  conversion  of  glucose  to  fatty  acids.  About
30%  of  the  vascular  supply  to  the  liver  comes  from  the
hepatic  artery  and  about  70%  from  the  hepatic  portal
vein.  The  ﬂow  in  the  portal  vein  comes  from  its  princi-
ple  tributaries:  the  splenic  vein,  the  superior  mesenteric
vein,  the  inferior  mesenteric  vein,  and  tributaries  that
empty  directly  into  the  hepatic  portal  vein  (the  left  gas-
tric  vein,  the  right  gastric  vein  and  the  superior  branch
of  the  posterior  duodenopancreatic  arcade).  The  insulin
content  of  these  tributaries  is  very  variable,  as  the  gastric
veins  contain  little  insulin  whereas  the  duodenopancreatic
arcades  contain  more  than  the  rest  of  the  portal  system.
The  drainage  of  these  veins  frequently  varies.  Left,  or
more  frequently  right  gastric  veins  can  be  seen  that  ﬂow
directly  into  the  liver  (mainly  into  segment  IV),  leading  to
a  lower  insulin  concentration  there  and  thus  resulting  in
a  patient,  who  moreover  has  hepatic  steatosis,  having  a
focal  area  of  hepatic  parenchyma  which  is  less  fatty  than
the  rest  of  the  liver  (Fig.  5).  Similarly,  the  superior  branch
of  the  duodenopancreatic  arcade  may  empty  not  into  the
portal  vein  itself  but  intrahepatically  near  the  hilum,  result-
ing  in  a  focal  area  that  receives  more  insulin  and  thus
becomes  more  fatty.  Figs.  6  and  7  illustrate  these  two
situations.
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feripherally distributed steatosis
he  appearance  of  peripheral,  subcapsular  predominance
f  hepatic  steatosis  is  particularly  misleading.  It  is  usually
bserved  in  patients  on  peritoneal  dialysis  with  intraperi-
oneal  administration  of  insulin,  the  insulin  being  absorbed
y  diffusion  through  the  portal  system.  This  method  is  used
y  some  teams  to  avoid  subcutaneous  insulin  injections
9].
ultiple pseudotumour steatosis
n  some  patients,  heterogeneous  steatosis  does  not  appear
s  a ﬁeld  but  as  multiple  lesions  that  are  more  fatty  than
he  rest  of  the  liver  and  distributed  throughout  the  whole
f  the  liver  parenchyma.  These  lesions  strongly  suggest  liver
umours.  They  are  hyperechoic  and  homogeneous  with  ultra-
ound,  hypoattenuating  in  all  CT  phases,  with  enhancement
heoretically  parallel  to  that  of  the  liver.  However,  there
s  often  a reduction  in  the  contrast  between  these  lesions
nd  the  rest  of  the  liver  in  the  late  phase.  MRI  with  an  in-
hase  and  opposed-phase  T1-weighted  sequence  will  show
he  fatty  nature  of  these  islets.  The  differential  diagnosis
s  naturally  with  other  multiple  fatty  tumours  with,  in  the
orefront,  the  steatotic  variety  of  hepatic  adenoma.  The
718  V.  Vilgrain  et  al.
Figure 6. Area spared by the fat in a steatotic liver; a, b: in-phase and opposed-phase sequences showing marked steatosis outside of
the lower part of segment IV which is hyperintense on the opposed-phase image; c, d: T1-weighted sequences with fat saturation before
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Dnjection (c) and in the portal phase (d). A vein can be seen directl
ein.
ultiplicity  of  lesions,  their  small  size  (less  than  2  cm)  and
heir  often  being  the  same  size,  enhancement  similar  to  the
iver  and  the  inconsistent  but  very  pathognomonic  presence
f  a  still  more  fatty  border  of  the  peripheral  part  of  these
atty  islets  are  features  favouring  pseudotumour  steatosis
Fig.  8).  Features  in  favour  of  diagnosis  of  multiple  hepatic
denomas  are  the  variable  size  of  the  lesions  and  possible
often  moderate)  increased  vascularisation  in  the  arterial
hase  [10,11].
typical focal fatty sparing
n  steatotic  patients,  a  rare  but  very  misleading  appearance
s  an  islet  of  healthy  liver,  or  one  containing  less  fat  than  the
est  of  the  liver  parenchyma,  outside  the  areas  particularly
xposed  to  different  insulin  concentrations.  The  differen-
ial  diagnosis  is  with  a  hepatic  tumour  in  a  steatotic  liver.
hese  particularly  misleading  forms  can  be  diagnosed  since
hey  do  not  show  hypervascularisation  in  a  combination  of
maging  examinations  (particularly  with  contrast-enhanced
ltrasound).
C
e
oering the liver (arrow). This is aberrant drainage of a right gastric
erivascular steatosis
ery  exceptionally  but  very  characteristically,  steatosis  may
redominate  around  vessels  (Fig.  9).  The  largest  series
eported  in  the  literature  consisted  of  ten  patients  in  whom
erivascular  steatosis  predominated  around  the  hepatic
eins  in  three,  around  the  portal  branches  in  ﬁve,  and  both
round  the  hepatic  veins  and  portal  branches  in  two  patients
12]. In  three  of  these  ten  patients,  perivascular  steatosis
as  not  recognised  on  the  CT  scan  and  the  diagnosis  was
orrected  by  MRI.  There  is  no  clear  explanation  for  this  very
articular  presentation  of  steatosis.
teatosis and hepatic tumours
iagnostic difﬁcultiesharacterisation  of  focal  liver  lesions  is  based  on  a  differ-
nt  non-contrast  enhanced  signal  and  different  behaviour
f  the  lesion  after  injection  relative  to  the  rest  of  the
Hepatic  steatosis:  A  major  trap  in  liver  imaging  719
Figure 7. Localised steatosis of the posterior part of segment IV: a, b: in-phase and opposed-phase T1-weighted MRI. The posterior part
of segment IV is hyperintense in phase (a) and there is a marked homogeneous signal drop on the opposed-phase image (b); c, d: CT scan
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clearer on the MIP reconstruction (d). This is aberrant drainage of t
liver,  the  liver  being  taken  as  the  reference.  During  steato-
sis,  the  ultrasound,  CT  and  MRI  signal  from  the  liver  is
modiﬁed;  on  the  one  hand,  this  may  lead  to  underestimat-
ing  liver  tumours,  particularly  with  CT,  and  on  the  other,
make  characterisation  of  the  lesion  more  difﬁcult.  MRI
is  the  most  appropriate  imaging  examination.  To  advance
with  the  diagnosis,  it  is  essential  to  take  into  account  all
T1-weighted  sequences,  not  only  the  in-phase  and  opposed-
phase  sequences  but  also  dynamic  and  diffusion  sequences
and  T2-weighted  sequences.
Peritumoral changes
Peritumoral  changes  can  be  seen  in  patients  with  hepatic
steatosis.  They  generally  produce  an  area  that  is  less
fatty  than  the  rest  of  the  liver  and  is  usually  seen
around  hypervascular  lesions  or  tumours,  whether  they  are
benign  (focal  nodular  hyperplasia,  ﬂash  ﬁlling  hemangioma)
or  hypervascular  malignant  tumours  (hepatocellular  carci-
noma,  endocrine  metastasis).  The  mechanism  of  this  area
spared  of  fat  is  not  completely  understood,  although  it  is
p
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s
lsegment IV. A vessel is seen directly entering the liver (c), much
perior branch of the posterior duodenopancreatic arcade.
robably  a  matter  of  remodelling  related  to  modiﬁcation
f  the  vascularisation.  The  increased  arterialisation  of  the
umour  is  frequently  associated  with  an  increased  arte-
ial  supply  to  the  surrounding  territory,  which  explains  the
ecrease  in  fat  concentration.  In  imaging,  the  appearance
s  misleading  as  these  changes  can  look  like  a  peritu-
oral  capsule.  They  are  clearly  visible  with  CT  and  even
etter  with  MRI  where  a  hyperintense  ‘‘collar’’  between
he  lesion  and  the  rest  of  the  liver  can  be  seen  on
pposed-phase  T1-weighted  images;  this  collar  is  invisible  in
n-phase  T1-weighted,  T2-weighted  and  diffusion  sequences
Figs.  10  and  11).
More  rarely,  peritumoral  changes  may  be  the  result  of  a
hange  in  insulin  concentration  around  the  lesion.  Thus,  very
haracteristically,  there  is  localised  steatosis  around  liver
etastases  of  insulinomas.  Here  again,  this  collar  with  signal
rop  on  opposed-phase  images  must  not  be  interpreted  as  a
erilesional  capsule.  Superimposition  of  in-phase,  opposed-
hase,  and  fat  saturation  T1-weighted  images  and  other
equences  (T2-weighted  and  diffusion)  helps  locate  the
esion  and  identify  peritumoral  changes  (Fig.  12).
720  V.  Vilgrain  et  al.
Figure 8. Multiple pseudotumour steatosis: a, b: in-phase and opposed-phase T1-weighted sequences showing discretely hyperintense
in-phase lesions (a), signal drop on the opposed-phase image (b). Note the even more pronounced signal drop around the lesions; c, d: with
fat saturation T1-weighted sequence and after injection, the enhancement of these lesions is parallel to that of the rest of the liver; e:
with fat suppression T2-weighted sequence, the lesions are very discretely hyperintense.
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Figure 9. Perivascular steatosis: a—c: in-phase (a), opposed-phase (b), and fat saturation (c) T1-weighted sequences MRI. Presence of
hyperintensity on both sides of the left branch of the portal vein in phase, with a massive signal drop on the opposed-phase image (b). The
signal drop is much more moderate in the fat saturation sequence (c); d: no abnormality is visible in the T2-weighted sequence with fat
suppression.
722  V.  Vilgrain  et  al.
Figure 10. Flash ﬁlling hemangioma in a steatotic liver. Presence of peritumoral changes: a; b: with in-phase (a) and opposed-phase (b)
T1-weighting, a subcapsular hypointense lesion measuring a centimetre can be seen in the right liver. Presence of perilesional hyperintensity
on the opposed-phase image; c, d: in T1-weighting after injection of gadolinium chelates in the arterial and portal phases, clear massive
hypervascularisation of the lesion persisting in the late phase; e: with T2-weighting, this centimetre lesion is clearly hyperintense.
Hepatic  steatosis:  A  major  trap  in  liver  imaging  723
Figure 11. Subcapsular splenosis of the left liver: a; b: in-phase (a) and opposed-phase (b) T1-weighted sequences. Discretely heteroge-
neous signal drop of the entire liver, indicating marked steatosis. Presence of a subcapsular hypointense lesion of the left lobe, surrounded
by a hyperintense border on the opposed-phase image; c, d: T1-weighted sequences after injection of gadolinium chelates in the arterial
phase (c) and late phase (d), which shows clear increased arterialisation of the lesion; e: discretely hyperintense subcapsular lesion with
fat suppressed T2-weighted sequence; f: coronal view of contrast-enhanced CT showing no spleen in place. Presence of another site of
splenosis in the left hypochondrium. This patient had had a splenectomy secondary to trauma. Opposed-phase T1-weighted image showing
the hyperintense border around a highly arterialised lesion in a steatotic liver.
724  V.  Vilgrain  et  al.
Figure 12. Hepatic metastasis of an insulinoma: a; b: in-phase and opposed-phase T1-weighted MRI: a lesion is visible in the posterior
section of the right liver, surrounded by a border which shows opposed-phase signal drop (b); c: with contrast-enhanced T1-weighted
s  arterialised; d: in a diffusion-weighted sequence, clear hyperintensity
o round the lesion. The localised steatosis is induced by the local secretion
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TAKE-HOME  MESSAGES
General  concepts
• Hepatic  steatosis  is  a common  condition.
• Its  prevalence  is  increasing.
• Imaging  (ultrasound,  CT  and  MRI)  provides  theequence after injection of gadolinium chelates, the lesion is highly
f the lesion surrounded by a hypointense halo indicating steatosis a
f insulin.
The  opposite  mechanism  can  be  seen  with  liver  metas-
ases  of  glucagonomas  in  patients  with  diffuse  hepatic
teatosis.  In  this  case,  the  area  spared  by  fat  around  the
esions  is  induced  by  local  secretion  of  hormones  [13].
onclusion
n  conclusion,  hepatic  steatosis  is  common  and  increasing.
ts  atypical  forms  are  easy  to  recognise  in  imaging.  When
t  is  heterogeneous  it  is  frequently  misleading.  MRI  and  the
athophysiology  help  provide  the  correct  diagnosis  in  most
ases.
diagnosis  easily  when  it  presents  in  its  classic  form.
• MRI  with  in-phase  and  opposed-phase  T1-weighted
sequences  is  essential  when  the  presentation  is
atypical.
Hepatic  steatosis:  A  major  trap  in  liver  imaging  
Principle  results
• Localised  steatosis  and  areas  spared  of  fat  in  a
steatotic  liver  predominate  around  the  hilum.
• These  locations  are  explained  by  aberrant
intrahepatic  drainage  of  veins  of  the  hepatic
portal  system.
• Aberrant  venous  drainage  modiﬁes  the  local
concentration  of  insulin.
• Multiple  pseudotumour  steatosis  mimics  fatty
intrahepatic  tumours  and,  in  ﬁrst  place,
hepatocellular  adenomas.
• In  certain  cases,  steatosis  may  predominate  in  the
periphery  or  around  the  portal  vessels  or  hepatic
veins.
• Hepatic  steatosis  makes  characterising  liver  tumours
more  difﬁcult.
• In  the  steatotic  liver,  peritumoral  changes  can  be
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3seen  around  hypervascular  liver  lesions
Clinical caseThis  73-year-old  man,  with  no  particular  medical  history,
has  had  a  lesion  of  the  posterior  surface  of  the  left  lobe
since  2010.  Two  MRIs,  performed  two  years  apart,  show  the
Figure 13. a, b: hepatic ultrasound centered on the left lobe (transve725
esion  to  be  stable.  His  imaging  examinations  are  visible  in
igs.  13  and  14.
uestions
.  Describe  the  abnormalities.
. What  do  you  surmise  as  the  diagnosis?
.  How  would  you  conﬁrm  the  diagnosis?
nswers
.  There  is  a  homogeneous,  hyperechoic,  non-nodular  ﬁeld
on  the  posterior  surface  of  the  left  lobe  in  the  ultra-
sound  examination.  With  MRI,  the  lesion  is  not  visible  on
T2-weighted  sequence,  is  hypointense  on  T1-weighted
sequence  before  injection  and  little  different  from  the
liver  after  injection.
.  The  hardly  nodular  character,  the  presence  of  fat  in  the
lesion  and  the  site  suggest  heterogeneous  steatosis.
.  The  diagnosis  can  be  conﬁrmed  by  ﬁnding  a  vein  enter-
ing  the  lesion.  This  is  visible  in  Fig.  14d  but  will  be
easier  to  identify  with  Doppler  ultrasound  (Fig.  15).
Contrast-enhanced  ultrasound  will  show  lesion  enhance-
ment  identical  to  that  of  the  liver  (Fig.  16).  The  diagnosis
is  that  of  heterogeneous  steatosis  of  the  left  lobe  with
aberrant  drainage  of  a branch  of  the  portal  system  into
the  liver  lesion.
rse and longitudinal slices).
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Figure 14. Hepatic MRI: T2-weighted (a), T1-weighted with fat suppression (b), after injection of gadolinium chelates in the arterial and
portal phases (c and d). The in-phase and opposed-phase T1-weighted sequences are not presented because of many artefacts but show a
signal drop at the posterior surface of the left lobe.
Figure 15. Doppler ultrasound.
Figure 16. Contrast-enhanced ultrasound.
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